Part V: A Critical Summary
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 91)
The three papers presented in this section involve some consideration of the potential usefulness of estrogen receptors (ER) in the planning of adjuvant therapy for breast cancer. Hence the problem is briefly reviewed.
KeywordsBreast Cancer Estrogen Receptor Primary Breast Cancer Adjuvant Trial Hormone Dependence
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.Háhnel R (1982) Steroid receptor status, tumor growth and prognosis. In: Stoll BA (ed) Endocrine relationship in breast cancer. Heinemann Medical, London, p 107Google Scholar
- 3.Bonadonna G, Bignami P, Buzzoni R, Moliterni A, Valagussa P, Veronesi U (1983) New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. This book, pp 210–213Google Scholar
- 8.Palshof T (1981) Adjuvant endocrine therapy in the management of primary breast cancer. Reviews on Endocrine-Related Cancer (Suppl) 7: 65Google Scholar
- 9.Wallgren A, Baral E, Glas U, Kaigas M, Karnstróm L, Nordenskjóld B, Theve NO, Wilking N, Silfverswárd C (1981) Adjuvant breast cancer treatment with tamoxifen and combination chemotherapy in post-menopausal women. In: Salmon S, Jones SE (eds) Adjuvant therapy of cancer III. Grune and Stratton, New York, p 345Google Scholar
- 12.Sarfaty GA, Nash AR, Keightley DD (eds) (1981) Estrogen receptor assay in breast cancer. Laboratory discrepancies and quality assurance. Masson, New YorkGoogle Scholar
© Springer-Verlag Berlin · Heidelberg 1984